Related Experiment Video
Updated: Jun 16, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Development, structure, and implementation of cardiometabolic clinics in the United States, with a focus on
Jodeanna Sweeney1, Jason Liu2, Gregory Warren3
1Division of Bariatric Surgery, School of Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.
Insights
Cardiometabolic clinics (CMCs) offer comprehensive care for metabolic syndrome, improving patient outcomes and reducing healthcare costs. Implementing CMCs is key to managing the growing cardiovascular-kidney-metabolic syndrome burden.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
- Public Health
Background:
- Metabolic syndrome affects over one-third of US adults, increasing risks for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
- This cluster of conditions is now termed cardiovascular-kidney-metabolic (CKM) syndrome, posing significant clinical and economic challenges.
- Current care for patients with multimorbidity is often fragmented and suboptimal, despite existing guidelines.
Purpose of the Study:
- To outline key considerations for developing, structuring, and implementing Cardiometabolic Clinics (CMCs) in the US.
- To highlight the potential of CMCs in delivering comprehensive, preventive care for cardiometabolic risk factors and diseases.
- To address the growing clinical and economic burden of CKM syndrome through a structured care model.
Main Methods:
- Review of existing US-based CMC models, including the comprehensive care model and the Cardiometabolic Center Alliance - Cardiometabolic Center of Excellence model.
- Emphasis on developing financial models for return on investment, defining target populations, and establishing care delivery plans.
- Leveraging digital solutions for improved patient access and engagement, alongside essential team training across cardiometabolic conditions.
Main Results:
- CMCs demonstrate increased uptake of guideline-directed medical therapies and improved cardiometabolic outcomes in studies.
- Benefits for healthcare providers include enhanced communication, convenience, and reduced redundant testing and visits, leading to cost savings.
- Scalability of CMCs is crucial due to the rising prevalence of CKM syndrome.
Conclusions:
- CMCs offer a promising multidisciplinary approach to managing CKM syndrome, potentially reducing its clinical and economic burden.
- Successful implementation requires strategic planning, financial modeling, and a focus on team training and digital integration.
- Further large-scale, long-term studies are needed to fully validate the long-term impact and efficacy of CMCs.
Abstract:
Metabolic syndrome and associated cardiometabolic risk factors affect over one‑third of US adults, increasing the risk for atherosclerotic cardiovascular disease, type 2 diabetes, and chronic kidney disease. Recently termed cardiovascular-kidney-metabolic syndrome, the syndrome contributes to substantial clinical and economic burden. Despite guideline recommendations, affected patients who have multimorbidity often receive suboptimal, fragmented care. Cardiometabolic clinics (CMCs) comprise a multidisciplinary team that deliver comprehensive, preventive care to patients with cardiometabolic risk factors and diseases. This review outlines key considerations for the development, structure, and implementation of CMCs in the US. Initial steps include developing a financial model to demonstrate potential return on investment, defining the target patient population, establishing care delivery and operational plans, such as cost coverage evaluations, and leveraging digital solutions to improve access and engagement. The proposed CMC structure comprises a core team of a navigator and specialist in cardiometabolic diseases, based on two US-based models: the comprehensive care model and Cardiometabolic Center Alliance - Cardiometabolic Center of Excellence model. Training the team across cardiometabolic conditions is essential. Once established, demonstrating a positive return on investment can support expanding the team to additional specialties. Scalability remains crucial due to the rising prevalence of cardiovascular-kidney-metabolic syndrome. Studies show CMCs increase uptake of guideline-directed medical therapies and improve cardiometabolic outcomes, although larger, long-term studies are needed. Benefits also extend to healthcare providers, including improved communication, greater convenience, and reduced redundant tests and visits, supporting cost savings. CMCs can potentially reduce the clinical and economic burden of cardiovascular-kidney-metabolic syndrome in the US.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
